News (1892757)

Hilton Grand Vacations : HGV Investor Overview PU
Paris Pride revelers fear for safety if far-right wins election RE
Transcript : Northwest Biotherapeutics, Inc. - Shareholder/Analyst Call
RIVN Investors Have Opportunity to Lead Rivian Automotive, Inc. Securities Fraud Lawsuit PR
Russian attack on southeastern Ukrainian town kills seven, official says RE
DEME : expands green hydrogen portfolio with HYPORT production facility in Egypt PU
Egypt looking to raise target for renewable energy to 58% by 2040 RE
Thousands march in Paris Pride ahead of elections RE
China issues rare earth regulations to further protect domestic supply RE
Far-right Alternative for Germany reports surge in membership RE
MASCC/AFSOS/ISOO 2024 Annual Meeting Features Presentation of Important Preliminary Data in Cryotherapy Side-Effect Management for Safety & Efficacy of Paxman Limb Cryocompression Device AQ
Kemi Badenoch urges ex-Tory voters to return and not support Reform AN
Exponent : Commercialization Challenges for Solid-State Battery Systems PU
Nestle sees stable sales growth from Q2, CEO tells paper RE
NEW: Bertelsmann Environmental Report 2023 PU
NEU: Bertelsmann Environmental Report 2023 PU
GlobalData : EUDR could cost EU consumers up to $1.5 billion, as new sustainability rules set to impact global commodity supply chains, says new GlobalData study PU
Vietnam Q2 GDP growth accelerates; inflation pressure rises RE
China tightens law on handling disasters including information flows RE
GreenPower Motor : 2024 Q4 MD&A PU
XP Inc. Announces Pricing of Senior Notes Offering BU
Cementir N : Betaling aan overheden PU
Bank of America : CCAR Form 8-K PU
Critical Metals Corp. Joins Russell 2000®, Russell 3000® and Russell Microcap® Indexes AQ
Marcus & Millichap : Arranges The Sale Of Former Perkins Property in Iowa PU
Mandalay Resources : ESG 2023 Report PU
Arizona Metals Corp Announces Annual General Meeting Results AQ
Rock Tech held its 2024 Annual General and Special Meeting of Shareholders PR
Lithium Ionic Executes Definitive Agreement for US$20 Million Royalty Financing with Appian Capital AQ
Carbon Done Right Developments Inc. Announces Extension to MCTO NE
Arvida : FY2024 Annual Report PU
Packaging of America : Sustainibility Report (PCA 2023 Responsibility Report) PU
Aimfinity Investment Corp. I Announces Extension of the Deadline for an Initial Business Combination to July 28, 2024 AQ
Marinus Pharmaceuticals : Corporate Overview Slide Deck PU
Metalla Renews Base Shelf Prospectus NE
Masimo : Investor Presentation June 2024 PU
Roscan Gold : Financial Statements PU
ALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera Sciences, Inc. - ALIM BU
Kirby McInerney LLP Reminds Scotts Miracle-Gro Company (SMG) Investors of Class Action Filing and Encourages Investors to Contact the Firm BU
Rumo S A : Comunicado ao Mercado PU
HubSpot : Statement Regarding June 22, 2024 Security Incident PU
US, India extend digital tax truce to Sunday as deadline approaches RE
Apollo Reports Annual General Meeting Results; Management Change Update AQ
ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC GL
FedEx : Fourth Quarter 2024 Transcript PU
1234NextSee all

Companies (1981)

TARGET CORPORATION 68 489 M $
Logo Target Corporation

Target Corporation specializes in retail distribution. Net sales break down by family of products as follows: - household and beauty products (26.5%) ; - furnishings and decorative items (19.7%) ; - food and beverage (19.6%); - electronic products, sp ...

KKR & CO. INC. 93 390 M $
Logo KKR & Co. Inc.

KKR & Co. Inc. is an investment company, which offers alternative asset management as well as capital markets and insurance solutions. The Company's asset management business offers a range of investment management services to fund investors around the wo ...

INTESA SANPAOLO S.P.A. 67 276 M $
Logo Intesa Sanpaolo S.p.A.

The Intesa Sanpaolo Group is one of the first European groups to have made a strong commitment to ESG. It is also the first in the world, in terms of social impact, to focus on the climate. The group is the leader in Italy (13.6 million clients; >3,300 br ...

SAFRAN 87 464 M $
Logo Safran

Safran is a high technology international group, a leading equipment provider in the Aerospace and Defense markets. The group specializes in the design, manufacturing, and marketing of equipment and systems of high technology mechanical and electronic equ ...

THE TRADE DESK, INC. 47 788 M $
Logo The Trade Desk, Inc.

The Trade Desk, Inc. specializes in the development and operation of an online platform dedicated to the purchase of advertising space. Based on data, the platform allows advertisers to optimize the placement, execution and management of advertising campa ...

ALNYLAM PHARMACEUTICALS, INC. 30 738 M $
Logo Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. is a clinical-stage company. The Company is engaged in developing mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead product candidate, Descartes-08, is an autologous mRNA CAR-T directed agains ...

CHINA MERCHANTS SECURITIES CO., LTD. 15 214 M $
Logo China Merchants Securities Co., Ltd.

CHINA MERCHANTS SECURITIES CO., LTD is a China-based company, principally engaged in security businesses. The Company operates its businesses through brokerage and wealth management business, including stocks, funds, bonds and financial products trading; ...

BIONTECH SE 19 392 M $
Logo BioNTech SE

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell ...

SAREPTA THERAPEUTICS, INC. 14 935 M $
Logo Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modali ...

CNA FINANCIAL CORPORATION 12 498 M $
Logo CNA Financial Corporation

CNA Financial Corporation is an insurance holding company. The Company’s segments include Specialty, Commercial and International, and Life & Group and Corporate & Other. The Specialty segment offers management and professional liability and other cover ...

ANTERO RESOURCES CORPORATION 10 142 M $
Logo Antero Resources Corporation

Antero Resources Corporation is an independent natural gas and natural gas liquids (NGLs) company. The Company is engaged in the acquisition, development and production of unconventional properties located in the Appalachian Basin in West Virginia and Ohi ...

ZOMATO LIMITED 20 781 M $
Logo Zomato Limited

Zomato Limited operates as an Internet portal that helps in connecting the users, restaurant partners and delivery partners. The Company also provides platform to restaurant partners to advertise themselves to the target audience in India and abroad and s ...

HOLOGIC, INC. 17 328 M $
Logo Hologic, Inc.

Hologic, Inc. is the world leader in the design, manufacturing and marketing of diagnostic products, medical imaging systems and surgical products dedicated to women's health. Net sales break down by area of application as follows: - molecular diagnostic ...

IMMUNOGEN, INC. 8 359 M $
Logo ImmunoGen, Inc.

ImmunoGen, Inc. is a commercial-stage biotechnology company. The Company is focused on developing and commercializing of antibody- drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company's technology comprises an antibody t ...

CEREVEL THERAPEUTICS HOLDINGS, INC. 7 450 M $
Logo Cerevel Therapeutics Holdings, Inc.

Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous ...

LEGEND BIOTECH CORPORATION 8 073 M $
Logo Legend Biotech Corporation

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), refe ...

REVOLUTION MEDICINES, INC. 6 403 M $
Logo Revolution Medicines, Inc.

Revolution Medicines, Inc. is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refer ...

LOONGSON TECHNOLOGY CORPORATION LIMITED 4 847 M $
Logo Loongson Technology Corporation Limited

Loongson Technology Corp Ltd is a China-based company mainly engaged in the research, development, manufacturing, and servicing of computer processing units (CPU) and related chips. The Company's main products include Loongson series CPU and related chips ...

ROIVANT SCIENCES LTD. 7 808 M $
Logo Roivant Sciences Ltd.

Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company that seeks to improve the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline is focused on inflammation and immun ...

XPENG INC. 6 925 M $
Logo XPeng Inc.

Xpeng Inc is a China-based company engaged in design, development, production and sales of smart electric vehicles (Smart EV). The Company's primary products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P ...

IONIS PHARMACEUTICALS, INC. 6 951 M $
Logo Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development a ...

OLIN CORPORATION 5 631 M $
Logo Olin Corporation

Olin Corporation is a vertically integrated global manufacturer and distributor of chemical products and a manufacturer of ammunition. The Company operates through three segments: Chlor Alkali Products and Vinyls, Epoxy and Winchester. The Chlor Alkali Pr ...

UBIQUITI INC. 8 807 M $
Logo Ubiquiti Inc.

Ubiquiti Inc. is engaged in developing technology platforms for distributed Internet access, unified information technology, and consumer electronics for professional, home and personal use. Its solutions are categorized into three categories: networking ...

PI INDUSTRIES LIMITED 6 910 M $
Logo PI Industries Limited

PI Industries Limited is a holding company. The Company is engaged in the manufacturing and distribution of agro chemicals. The Company operates through two segments: Agro chemicals, and Pharma. The Agro chemicals segment includes Agchem exports (CSM) and ...

BLUE OWL CAPITAL CORPORATION 5 986 M $
Logo Blue Owl Capital Corporation

Blue Owl Capital Corporation is a specialty finance company focused on lending to United States middle-market companies. The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation by targeting investme ...

CREDIT ACCEPTANCE CORPORATION 6 233 M $
Logo Credit Acceptance Corporation

Credit Acceptance Corporation is engaged in offering that enable automobile dealers to sell vehicles to consumers. The Company’s financing programs are offered through a nationwide network of automobile dealers. Its loan portfolio consists of two portfo ...

CYBERARK SOFTWARE LTD. 11 797 M $
Logo CyberArk Software Ltd.

CyberArk Software Ltd is an Israel-based provider of information technology (IT) security solutions that protect organizations from cyber-attacks. The Company's software solutions are focused on protecting privileged accounts, which have become a critical ...

TWILIO INC. 9 724 M $
Logo Twilio Inc.

Twilio Inc. provides a customer engagement platform comprising communications application programming interfaces. It enables developers to embed numerous forms of messaging, voice, and email interactions into their customer-facing applications, and softwa ...

FIVE BELOW, INC. 6 001 M $
Logo Five Below, Inc.

Five Below, Inc. is a specialty value retailer offering merchandise targeted at the tween and teen demographic. Its assortment of products, including select brands and licensed merchandise. It is engaged in offering a group of products, including leisure, ...

CHORD ENERGY CORPORATION 6 991 M $
Logo Chord Energy Corporation

Chord Energy Corporation is an independent exploration and production company, which is engaged in the acquisition, exploration, development and production of crude oil, natural gas liquids (NGL) and natural gas. The Company’s operations are focused on ...

TELEFÓNICA DEUTSCHLAND HOLDING AG 6 986 M $
Logo Telefónica Deutschland Holding AG

Telefonica Deutschland Holding AG is a Germany-based company in the telecommunications sector. The Company offers mobile and fixed-line services, providing voice, data and other services to private and business customers, as well as digital products and s ...

VAXCYTE, INC. 8 215 M $
Logo Vaxcyte, Inc.

Vaxcyte Inc. is a clinical-stage vaccine company. It is engaged in developing a spectrum conjugate and protein vaccines to prevent or treat bacterial infectious diseases. Its lead candidate, VAX-24, is a Phase III-ready 24-valent, carrier-sparing pneumoco ...

MURPHY OIL CORPORATION 6 292 M $
Logo Murphy Oil Corporation

Murphy Oil Corporation is an independent oil and gas exploration and production company. The Company is engaged in both onshore and offshore operations and properties. The Company’s geographic segments include the United States, Canada, and all other co ...

EXACT SCIENCES CORPORATION 7 796 M $
Logo Exact Sciences Corporation

Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Co ...

CONROY GOLD AND NATURAL RESOURCES PLC 4 M $
Logo Conroy Gold and Natural Resources plc

Conroy Gold and Natural Resources PLC is a resource company, which is engaged in exploring and developing gold projects in Ireland and Finland. Its projects include Clay Lake Gold Target, Clontibret Gold Target, Slieve Glah Gold Targets, Glenish Gold Targ ...

ICENI GOLD LIMITED 11 M $
Logo Iceni Gold Limited

Iceni Gold Limited is an Australia-based gold exploration company that is exploring the 14 Mile Well Project in the Laverton Greenstone Belt of Western Australia. The project is situated midway between the gold mining townships of Leonora and Laverton and ...

OMAT ADVANCED MATERIALS (GUANGDONG) CO.,LTD. 453 M $
Logo Omat Advanced Materials (Guangdong) Co.,Ltd.

OMAT Advanced Materials Guangdong Co Ltd is a China-based company principally engaged in the research, development, production and sales of high-performance sputtering targets. The Company's main products include copper target, aluminum target, molybdenum ...

KONFOONG MATERIALS INTERNATIONAL CO., LTD 1 737 M $
Logo Konfoong Materials International Co., Ltd

Konfoong Materials International Co Ltd is a company engaged in research, development, production and sales of sputtering targets. The Company's products include aluminum targets, titanium targets, tantalum targets and tungsten-titanium targets, which are ...

PIERIS PHARMACEUTICALS, INC. 13 M $
Logo Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals, Inc. is a biotechnology company, which discovers and develops Anticalin-based drugs to target validated disease pathways. The Company’s clinical pipeline consists of immuno-oncology (IO), bispecific in partnership with collaborat ...

ACEPODIA, INC. 443 M $
Logo Acepodia, Inc.

Acepodia Inc is engaged in the research and development of new anti-cancer drugs. The Company uses antibody-cell conjugation (ACC) and immune cells. The products include Gamma delta 2T cell platform including ACE1831 (ACE-gdT-CD20) an antibody linked to s ...

HALCONES PRECIOUS METALS CORP. 3 M $
Logo Halcones Precious Metals Corp.

Halcones Precious Metals Corp. is a Canada-based exploration company focused on gold, silver and copper exploration. The Company is engaged in exploring for and developing gold-silver projects in the Maricunga Belt, Chile, the premiere gold mining distric ...

DELTA-FLY PHARMA, INC. 33 M $
Logo Delta-Fly Pharma, Inc.

Delta-Fly Pharma, Inc. is a Japan-based company principally engaged in the research, development, manufacture and sale of pharmaceuticals. The Company's development pipeline includes anticancer drug candidate compound DFP-10917 whose target disease is ref ...

PINEHRST CA 150 253 $
Logo PINEHRST CA

Halcones Precious Metals Corp. is a Canada-based exploration company focused on gold, silver and copper exploration. The Company is engaged in exploring for and developing gold-silver projects in the Maricunga Belt, Chile, the premiere gold mining distric ...

THOR MEDICAL 23 M $
Logo Thor Medical

Thor Medical ASA, formerly Nordic Nanovector ASA, is a Norway-based biopharmaceutical company. The Company is engaged in the development and commercialization of targeted therapeutics for hematological cancers. Its main product is Betalutin, a CD37-target ...

BETAWAVE CORPORATION 5 $
Logo Betawave Corporation

Betawave Corporation provides online marketing solutions for Websites targeting youth and moms. The Company specializes in aggregating and distributing marketing content on a selected network of targeted sites, mostly virtual worlds and gaming, for which ...

EXICURE, INC. 3 M $
Logo Exicure, Inc.

Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company is into exploring strategic alternatives to maximize stockholder value. It is engaging in ...

BOWEN ACQUISITION CORP 97 M $
Logo Bowen Acquisition Corp

Bowen Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. The Co ...

OCEAN BIOMEDICAL, INC. 48 M $
Logo Ocean Biomedical, Inc.

Ocean Biomedical, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The Company helps to accelerates the development and commerciali ...

NOTABLE LABS, LTD. 6 M $
Logo Notable Labs, Ltd.

Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of the ...

DELTAGEN INC. 3 257 $
Logo Deltagen Inc.

Deltagen, Inc. is a provider of drug discovery tools and services to the biopharmaceutical industry. The Company offers a suite of programs designed to manage the efficiency of drug discovery, including access to biological models, as well as both small-m ...

RENEURON GROUP PLC 2 M $
Logo ReNeuron Group plc

ReNeuron Group plc is a United Kingdom-based clinical-stage stem cell company. The Company is engaged in the development of stem cell therapies targeting areas of unmet or poorly met medical need. It has developed a stem cell-derived, exosome-based, drug ...

EQUILLIUM, INC. 24 M $
Logo Equillium, Inc.

Equillium, Inc. is a clinical-stage biotechnology company. It is engaged in developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. The Company’s pipeline consists of immunomodulatory assets and ...

BICYCLE THERAPEUTICS PLC 1 394 M $
Logo Bicycle Therapeutics plc

Bicycle Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully sy ...

AURA RENEWABLE ACQUISITIONS PLC 729 839 $
Logo Aura Renewable Acquisitions plc

Aura Renewable Acquisitions plc is a United Kingdom-based holding company. The principal activity of the Company is focused on targeting various businesses operating in the global renewable energy sector supply chain. The purpose of the Company is to seek ...

HYUNGJI INNOVATION & CREATIVE CO.,LTD 12 M $
Logo HYUNGJI INNOVATION & CREATIVE Co.,Ltd

HYUNGJI Innovation and Creative Company Limited, formerly WOOSUNG INNOVATION & CREATIVE Co.,Ltd is a Korea-based company engaged in the manufacture and marketing of men’s apparels. The Company has four principal brands: YEZAC, which is a luxury styling ...

ABL BIO INC. 785 M $
Logo ABL Bio Inc.

ABL Bio Inc. is a company mainly engaged in the development of biopharmaceuticals. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific ...

COMPASS THERAPEUTICS, INC. 138 M $
Logo Compass Therapeutics, Inc.

Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company is developing proprietary antibody-based therapeutics to treat multiple human diseases. Its pipeline of novel product candidates is designed to target ...

PERSEUS PROTEOMICS INC. 37 M $
Logo Perseus Proteomics Inc.

Perseus Proteomics Inc is a Japan-based company principally engaged in the research, development, manufacture and sale of pharmaceuticals. The Company is involved in the research and development of therapeutic drugs for cancer and other diseases and relat ...

APOGEE THERAPEUTICS, INC. 2 300 M $
Logo Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and ...

IKENA ONCOLOGY, INC. 80 M $
Logo Ikena Oncology, Inc.

Ikena Oncology, Inc. is a targeted oncology company. The Company is focused on developing differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. The ...

BIOMX INC. 23 M $
Logo BiomX Inc.

BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, ...

SAGE THERAPEUTICS, INC. 654 M $
Logo Sage Therapeutics, Inc.

Sage Therapeutics, Inc. is a biopharmaceutical company. The Company has developed the two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. The Company is targeting diseas ...

CIDARA THERAPEUTICS, INC. 54 M $
Logo Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc. is a biotechnology company. The Company is developing targeted immunotherapies designed for patients facing serious diseases. The Company’s portfolio comprises various treatment and prevention paradigms, including drug-Fc conju ...

CHEMOMAB THERAPEUTICS LTD. 13 M $
Logo Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd, formerly known as Anchiano Therapeutics Ltd, is a Israel-based biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of cancers. Its therapeu ...

PEGASUS DIGITAL MOBILITY ACQUISITION CORP. 61 M $
Logo Pegasus Digital Mobility Acquisition Corp.

Pegasus Digital Mobility Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesse ...

HAWKEYE SYSTEMS, INC. 4 M $
Logo Hawkeye Systems, Inc.

Hawkeye Systems, Inc. seeks to acquire, merge or consolidate with another company (a target business). The Company is pursuing opportunities to invest in, acquire, merge or consolidate with a target business participating in diversified industries, such a ...

CROWN BAUS CAPITAL CORP. 16 105 $
Logo Crown Baus Capital Corp.

Crown Baus Capital Corp. is focused on becoming a global acquisitions-based company targeting high-tech industries and financial services. The Company uses several consultants to assist in locating potential target companies and procure the financial reso ...

MERO PART 118 M $
Logo MERO PART

Mercato Partners Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more busi ...

REYNA GOLD CORP. 1 M $
Logo Reyna Gold Corp.

Reyna Gold Corp. is a Canada-based company focused on gold exploration in Northwestern Mexico. The Company’s principal business activity is the acquisition and exploration of mineral properties. Its projects include La Gloria, El Durazno, La Centella, a ...

ARIZ ACQU 13 M $
Logo ARIZ ACQU

Arisz Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Compa ...

VALUENCE MERGER CORP. I 84 M $
Logo Valuence Merger Corp. I

Valuence Merger Corp. I is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It has not select ...

ATLED CORP. 76 M $
Logo ATLED CORP.

ATLED CORP. is a Japan-based company mainly engaged in the development and sale of workflow products. The workflow products are the digitization of the business flow from deliberation, application, approval for various businesses. The main products are pa ...

SOCL CAP 182 M $
Logo SOCL CAP

Social Capital Suvretta Holdings Corp. I is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. ...

EXACT THERAPEUTICS 22 M $
Logo EXACT Therapeutics

Exact Therapeutics AS is a Norway-based clinical-stage biopharmaceutical company, which develops ultrasound-mediated technology platform for targeted therapeutic enhancement Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-med ...

INTERNATIONAL MEDIA ACQUISITION CORP. 87 M $
Logo International Media Acquisition Corp.

International Media Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It ...

METAL BANK LIMITED 6 M $
Logo Metal Bank Limited

Metal Bank Limited is a mineral exploration company, which holds a portfolio of copper, cobalt and gold exploration projects. It holds a 75% interest in the advanced Livingstone gold project located 140 kilometers (km) northwest of Meekatharra in Western ...

ERASCA, INC. 643 M $
Logo Erasca, Inc.

Erasca, Inc. is a clinical-stage precision oncology company. The Company is focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The Company has assembled a wholly owned or controlled RAS/MAP ...

C4 THERAPEUTICS, INC. 318 M $
Logo C4 Therapeutics, Inc.

C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on advancing targeted protein degradation science to create a new generation of small-molecule medicines that transform patients’ lives. By leveraging its proprietary Tar ...

LEAP THERAPEUTICS, INC. 75 M $
Logo Leap Therapeutics, Inc.

Leap Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing targeted and immuno-oncology therapeutics. Its advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-related protein 1 (D ...

ARCH BIOPARTNERS INC. 78 M $
Logo Arch Biopartners Inc.

Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targetin ...

ACASTI PHARMA INC. 27 M $
Logo Acasti Pharma Inc.

Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH ...

ALTENERGY ACQUISITION CORP. 74 M $
Logo AltEnergy Acquisition Corp.

AltEnergy Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The C ...

CANNA-GLOBAL ACQUISITION CORP 81 M $
Logo Canna-Global Acquisition Corp

Canna-Global Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It ...

ENPHYS ACQUISITION CORP. 163 M $
Logo Enphys Acquisition Corp.

Enphys Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It ...

ME THERAPEUTICS HOLDINGS INC. 64 M $
Logo ME Therapeutics Holdings Inc.

ME Therapeutics Holdings Inc. is a Canada-based biotechnology company. The Company is involved in the discovery and development of novel immuno oncology therapeutics targeting immune suppression in cancer. The Company’s lead candidate is a novel high af ...

FTAC EMERALD ACQUISITION CORP. 155 M $
Logo FTAC Emerald Acquisition Corp.

FTAC Emerald Acquisition Corp. is a blank check company. The Company is formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more busi ...

ICOSAVAX, INC. 778 M $
Logo Icosavax, Inc.

Icosavax, Inc. is a biopharmaceutical company. The Company uses its virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with a focus on life-threatening respiratory diseases. Its VLP platform technology is design ...

IMMUNOME, INC. 726 M $
Logo Immunome, Inc.

Immunome, Inc. is a biotechnology company engaged in developing targeted cancer therapies. The Company's portfolio pursues each target with a modality appropriate to its biology, including immunotherapies, radioligand therapies and Antibody-Drug Conjugate ...

KEYH ACQUPAR 25 M $
Logo KEYH ACQUPAR

Keyarch Acquisition Corporation is a blank check company. The Company is formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more bus ...

SOCL CAPI 241 M $
Logo SOCL CAPI

Social Capital Suvretta Holdings Corp. III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses ...

GOLDENSTONE ACQUISITION LIMITED 77 M $
Logo Goldenstone Acquisition Limited

Goldenstone Acquisition Limited is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more bus ...

PYXIS ONCOLOGY, INC. 195 M $
Logo Pyxis Oncology, Inc.

Pyxis Oncology, Inc. is a clinical-stage company focused on developing therapeutics to target difficult-to-treat cancers. The Company is building therapeutics that hold the potential for mono and combination therapies. Its clinical program portfolio inclu ...

CANTABIO PHARMACEUTICALS, INC. 24 348 $
Logo Cantabio Pharmaceuticals, Inc.

Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology company. The Company is focused on commercializing therapies and the intellectual property generated from its research and development activities for Parkinson’s disease (PD), Alzheimerâ ...

BIRCHTREE INVESTMENTS LTD. 1 M $
Logo Birchtree Investments Ltd.

Birchtree Investments Ltd. is a Canada-based investment company. The Company's business objective is to give its shareholders the opportunity to indirectly participate in investments in the early stages of a target company's development; technologies that ...

IGM BIOSCIENCES, INC. 405 M $
Logo IGM Biosciences, Inc.

IGM Biosciences, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing and delivering a new class of medicines to treat patients with cancer and autoimmune and inflammatory diseases. The Company’s pipeline of clinical and ...

MARBLEGATE ACQUISITION CORP. 128 M $
Logo Marblegate Acquisition Corp.

Marblegate Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The ...

COLOMBIER ACQUISITION CORP. II 218 M $
Logo Colombier Acquisition Corp. II

Colombier Acquisition Corp. II is a blank check company. The Company is formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has n ...

HULIC REIT, INC. 1 307 M $
Logo Hulic Reit, Inc.

Hulic Reit Inc is a Japan-based diversified real estate investment trust (REIT). The Trust aims to maximize unitholder value by maintaining and improving earnings over the medium to long term and by achieving growth in the size and value of assets under m ...

IO BIOTECH, INC. 77 M $
Logo IO Biotech, Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt ...

FUTURE MEDICINE CO., LTD. 15 M $
Logo Future Medicine Co., Ltd.

Future Medicine Co Ltd is a Korea-based company mainly engaged in the synthetic drug development business. The Company is engaged in the development and sale of anti-inflammatory and anti-fibrotic agents, targeted anticancer drugs, immune anticancer drugs ...


1234Next

No results for this search

  1. Stock Market
  2. Advanced search
  3. 코인가상계좌 [ @MOONPAY_CALL ] 코인가상계좌 우리 기업가상 경남은행가상계좌 target=_blank